Robert Kasdin - Apollo Commercial Independent Director
| ARI Stock | USD 9.19 0.01 0.11% |
Director
Mr. Robert A. Kasdin, is an Independent Director of the Company. He was one of our directors since April 2014. Mr. Kasdin has served as Senior Vice President and Chief Operating Officer of Johns Hopkins Medicine since July 2015, and as Chief Financial Officer of Johns Hopkins Medicine since 2018. Prior to joining Johns Hopkins Medicine, he served as Senior Executive Vice President of Columbia University from September 2002 to June 2015. Prior to joining Columbia University, he served as the Executive Vice President and Chief Financial Officer of the University of Michigan from 1997 to 2002. Before his service at the University of Michigan, he was the Treasurer and Chief Investment Officer for the Metropolitan Museum of Art in New York City from 1993 to 1997, and, from 1988 to 1992, served as Vice President and General Counsel for Princeton University Investment Company. He began his career as a corporate attorney at Davis Polk Wardwell LLP. Mr. Kasdin served on the Board of Directors of Noranda Aluminum Holding Corporation from February 2008 to March 2014 and the Harbor Funds since January 2014. Mr. Kasdin is also a trustee of the National September 11 Memorial Museum, a member of the Council on Foreign Relations, and a member of the board of directors of The Y in Central Maryland. Mr. Kasdin earned his A.B. from Princeton University and his J.D. from Harvard Law School since 2014.
| Age | 62 |
| Tenure | 10 years |
| Address | 9 West 57th Street, New York, NY, United States, 10019 |
| Phone | 212 515 3200 |
| Web | https://www.apollocref.com |
Robert Kasdin Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robert Kasdin against Apollo Commercial stock is an integral part of due diligence when investing in Apollo Commercial. Robert Kasdin insider activity provides valuable insight into whether Apollo Commercial is net buyers or sellers over its current business cycle. Note, Apollo Commercial insiders must abide by specific rules, including filing SEC forms every time they buy or sell Apollo Commercial'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robert Kasdin over three months ago Acquisition by Robert Kasdin of 7037 shares of Apollo Commercial subject to Rule 16b-3 | ||
Robert Kasdin over six months ago Acquisition by Robert Kasdin of 16447 shares of Apollo Commercial subject to Rule 16b-3 |
Apollo Commercial Management Efficiency
The company has Return on Asset of (0.0125) % which means that on every $100 spent on assets, it lost $0.0125. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0558) %, meaning that it generated no profit with money invested by stockholders. Apollo Commercial's management efficiency ratios could be used to measure how well Apollo Commercial manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to 0.01. The current Return On Capital Employed is estimated to decrease to 0.04. As of now, Apollo Commercial's Fixed Asset Turnover is decreasing as compared to previous years. The Apollo Commercial's current Asset Turnover is estimated to increase to 0.05, while Non Current Assets Total are projected to decrease to under 493.5 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Michael Stewart | Medical Properties Trust | 64 | |
| Kevin Jacobs | Omega Healthcare Investors | 47 | |
| Tim Berryman | Medical Properties Trust | N/A | |
| Elizabeth Pitman | Medical Properties Trust | 56 | |
| Kapila Anand | Omega Healthcare Investors | 67 | |
| Burke Whitman | Omega Healthcare Investors | 64 | |
| Lynne Sagalyn | Blackstone Mortgage Trust | 72 | |
| Barbara Hill | Omega Healthcare Investors | 67 | |
| Edward Lowenthal | Omega Healthcare Investors | 75 | |
| Henry Nassau | Blackstone Mortgage Trust | 65 | |
| Martin Edelman | Blackstone Mortgage Trust | 79 | |
| Caterina Mozingo | Medical Properties Trust | 52 | |
| Thomas Dobrowski | Blackstone Mortgage Trust | 76 | |
| Stephen Plavin | Omega Healthcare Investors | 60 | |
| Leonard Cotton | Blackstone Mortgage Trust | 70 | |
| Daniel Sparks | Medical Properties Trust | 57 | |
Management Performance
| Return On Equity | -0.0558 | ||||
| Return On Asset | -0.0125 |
Apollo Commercial Real Leadership Team
Elected by the shareholders, the Apollo Commercial's board of directors comprises two types of representatives: Apollo Commercial inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Apollo. The board's role is to monitor Apollo Commercial's management team and ensure that shareholders' interests are well served. Apollo Commercial's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Apollo Commercial's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anastasia CPA, Secretary CFO | ||
| Michael Salvati, Independent Chairman of the Board | ||
| Scott Prince, Independent Director | ||
| Eric Press, Director | ||
| Scott Weiner, Chief Officer | ||
| Carmencita Whonder, Director | ||
| Stuart Rothstein, President, Chief Executive Officer, Director | ||
| Stuart CPA, CEO President | ||
| Mark Biderman, Independent Director | ||
| Jai Agarwal, Chief Financial Officer, Treasurer, Secretary | ||
| Anastasia Mironova, Chief Financial Officer, Treasurer, Company Secretary | ||
| Hilary Ginsberg, IR Contact Officer | ||
| Pamela Carlton, Director | ||
| Robert Kasdin, Independent Director | ||
| Katherine Newman, Independent Director | ||
| Brenna Haysom, Independent Director |
Apollo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Apollo Commercial a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0558 | ||||
| Return On Asset | -0.0125 | ||||
| Profit Margin | (0.71) % | ||||
| Operating Margin | 0.47 % | ||||
| Current Valuation | 8.2 B | ||||
| Shares Outstanding | 138.18 M | ||||
| Shares Owned By Insiders | 0.65 % | ||||
| Shares Owned By Institutions | 65.68 % | ||||
| Number Of Shares Shorted | 4.15 M | ||||
| Price To Earning | 9.30 X |
Currently Active Assets on Macroaxis
When determining whether Apollo Commercial Real offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Apollo Commercial's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Apollo Commercial Real Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Apollo Commercial Real Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apollo Commercial Real. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Mortgage Real Estate Investment Trusts (REITs) space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apollo Commercial. If investors know Apollo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apollo Commercial listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.74) | Dividend Share 1.3 | Earnings Share (0.94) | Revenue Per Share 1.147 | Quarterly Revenue Growth (0.17) |
The market value of Apollo Commercial Real is measured differently than its book value, which is the value of Apollo that is recorded on the company's balance sheet. Investors also form their own opinion of Apollo Commercial's value that differs from its market value or its book value, called intrinsic value, which is Apollo Commercial's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apollo Commercial's market value can be influenced by many factors that don't directly affect Apollo Commercial's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apollo Commercial's value and its price as these two are different measures arrived at by different means. Investors typically determine if Apollo Commercial is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apollo Commercial's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.